Regenerative Medical Technology (RMTG) Other Working Capital Changes (2024 - 2025)
Regenerative Medical Technology (RMTG) posted quarterly Other Working Capital Changes of $5274.0 for Q4 2025, up 210.97% quarter-over-quarter from $1696.0 in Q1 2024.
Regenerative Medical Technology (RMTG) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Regenerative Medical Technology's Other Working Capital Changes history runs 2 years deep, the most recent figure standing at $5274.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes changed N/A year-over-year to $5274.0; the TTM figure through Dec 2025 stood at $5274.0 (up 210.97% YoY), while the FY2025 annual figure was $25274.0, up 1390.21% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $5274.0, up from $1696.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $5274.0 in Q4 2025, with the low at $1696.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,274.00 |
| Dec 31, 2025 | 5,274.00 |
| Dec 31, 2025 | 5,274.00 |
| Mar 31, 2024 | 1,696.00 |
| Mar 31, 2024 | 1,696.00 |
| Mar 31, 2024 | 1,696.00 |